We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

113 hedge funds and large institutions have $118M invested in iShares US Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $441K | Put options by funds: $206K

6.75% less ownership

Funds ownership: 99.65% → 92.89% (-6.8%)

10% less funds holding

Funds holding: 125 → 113 (-12)

10% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 30

18% less capital invested

Capital invested by funds: $143M → $118M (-$25.2M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
113
Holders Change
-12
Holders Change %
-9.6%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
27
Reduced
30
Closed
19
Calls
$441K
Puts
$206K
Net Calls
+$235K
Net Calls Change
+$235K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.15M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.32M
3
PGFC
Peapack-Gladstone Financial Corp
New Jersey
+$3.15M
4
Fisher Asset Management
Fisher Asset Management
Washington
+$2.48M
5
UBS Group
UBS Group
Switzerland
+$2.46M

Top Sellers

Rank Fund Capital Flow
1
EE
EWG Elevate
California
-$6.35M
2
RWP
RWA Wealth Partners
Massachusetts
-$5.05M
3
Goldman Sachs
Goldman Sachs
New York
-$3.92M
4
AWS
Atria Wealth Solutions
New York
-$3.22M
5
TRCT
Tower Research Capital (TRC)
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
101
SignatureFD
Georgia
$8K – – –
OLVIG
102
Oliver Lagore Vanvalin Investment Group
Michigan
$7K – – –
AA
103
Ancora Advisors
Ohio
$6K – – –
EWM
104
EPG Wealth Management
Georgia
$6K +$6.47K +105 New
BCWM
105
Bartlett & Co Wealth Management
Ohio
$5.09K – – –
BC
106
Bartlett & Co
Ohio
$5K – – –
SWA
107
SOA Wealth Advisors
New York
$4K – – –
NFSG
108
Newbridge Financial Services Group
Florida
$3K – – –
CAAS
109
Capital Asset Advisory Services
Michigan
$1K – – –
CWC
110
Carolinas Wealth Consulting
North Carolina
$1K – – –
NSIM
111
North Star Investment Management
Illinois
$1K – – –
TFA
112
Transamerica Financial Advisors
Florida
$1K – – –
Bank of Montreal
113
Bank of Montreal
Ontario, Canada
$506 +$147K +2,385 +39%
EE
114
EWG Elevate
California
– -$6.35M -99,462 Closed
RWP
115
RWA Wealth Partners
Massachusetts
– -$5.05M -79,083 Closed
BCM
116
Brookstone Capital Management
Illinois
– -$967K -14,868 Closed
CLOS
117
Compagnie Lombard Odier SCmA
Switzerland
– -$506K -7,920 Closed
CG
118
Colony Group
Massachusetts
– -$256K -4,011 Closed
PAG
119
Private Advisor Group
New Jersey
– -$221K -3,456 Closed
WWM
120
Western Wealth Management
Colorado
– -$219K -3,426 Closed
TCA
121
Transcend Capital Advisors
New Jersey
– -$215K -3,372 Closed
ESB
122
Essex Savings Bank
Connecticut
– -$211K -3,300 Closed
MML Investors Services
123
MML Investors Services
Massachusetts
– -$211K -3,300 Closed
PCMF
124
Private Capital Management (Florida)
Florida
– -$211K -3,300 Closed
VFG
125
V2 Financial group
Illinois
– -$211K -3,300 Closed
2 3 4
5
6

IHE Hedge Fund Activity: Q3 2022 in Review

113 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2022, worth a combined $118M — down 18% from $143M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of IHE and 8 opened new positions — a net loss of 11 holders — while 30 trimmed existing stakes and 27 added.

The largest buyer was Susquehanna International Group, adding an estimated $4.15M. The largest seller was EWG Elevate, exiting entirely with an estimated $6.35M sold.

  • 113 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2022, down from 125 in Q2 2022.
  • Funds reported $118M of iShares US Pharmaceuticals ETF stock for Q3 2022, down 18% quarter-over-quarter.
  • 8 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2022 and 19 closed out, a net change of -11 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2022 was Susquehanna International Group, an estimated $4.15M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2022 was EWG Elevate, an estimated $6.35M sold.

Based on aggregated 13F filings for Q3 2022.